Table 2.
Characteristics and outcome of the study population of CDI patients.
| Demographic characteristics | n = 102 |
| Mean age | 49.79 (15–97) |
| Male gender | 55 (53.92%) |
| Risk factors | |
| Average BMI | 25.69 |
| Total LOS (days) | 24.38 |
| LOS before CDI diagnosis | 11.89 |
| LOS after CDI diagnosis | 12.72 |
| Mean number of antibiotics use before CDI | 2.35 |
| Average antibiotic days before CDI | 14.61 |
| Postsurgical diagnosis | 46 (45.9%) |
| Clinical characteristics | |
| Average number of bowel movements | 5.59 |
| Days with diarrhea before diagnosis of CDI | 5.38 |
| Average leukocyte count | 13,897 |
| Fever | 55 (53.9%) |
| Outcome | |
| ≤28 day mortality | 18 (17.6%) |
| >28 day mortality | 5 (4.9%) |
| Median ATLAS score | 4 |
| Colectomy | 4 (3.9%) |
| Prior antibiotics used | |
| Third generation cephalosporins | 48 (47.05%) |
| Fluoroquinolones | 34 (33.3%) |
| Carbapenems | 26 (25.4%) |
| Clindamycin | 24 (23.52%) |
| Antibiotics used for the treatment of CDI | |
| Metronidazole | 58 (56.86%) |
| Vancomycin | 7 (6.86%) |
| Metronidazole + vancomycin | 37 (36.27%) |
CDI, Clostridium difficile infection; LOS, length of stay.